Polyamine compound deoxyspergualin inhibits heat shock protein-induced activation of immature dendritic cells

Cell Stress and Chaperones

Volumn 14, Issue 2, 2009, Pages 133-139

  Sugawara, Atsushi ^a   Torigoe, Toshihiko ^a   Tamura, Yasuaki ^a   Kamiguchi, Kenjiro ^a   Nemoto, Kyuichi ^b   Oguro, Hiroshi ^a   Sato, Noriyuki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIPPON KAYAKU CO LTD   (Japan)

Author keywords

Dendritic cells; Deoxyspergualin; HSP70; Immunosuppressant

Indexed keywords

15 DEOXYSPERGUALIN; CYTOKINE; GUS 1; GUS 7; HEAT SHOCK PROTEIN; METHOXYDEOXYSPERGUALIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; B7 ANTIGEN; GUANIDINE DERIVATIVE; HEAT SHOCK PROTEIN 70; POLYAMINE;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LASER MICROSCOPY; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CELL MEMBRANE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; METABOLISM; UPREGULATION;

ALEXA;

ANIMALS; ANTIGENS, CD80; CELL DIFFERENTIATION; CELL MEMBRANE; DENDRITIC CELLS; GUANIDINES; HSP70 HEAT-SHOCK PROTEINS; MICE; MICE, INBRED C57BL; POLYAMINES; PROTEIN BINDING; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 64049089075     PISSN: 13558145     EISSN: 14661268     Source Type: Journal    
DOI: 10.1007/s12192-008-0064-y     Document Type: Article

References (42)

1. Amada N, Okazaki H, Sato T, Ohashi Y, Kikuchi H (2005) Deoxyspergualin prophylaxis with tacrolimus further improves long-term graft survival in living-related renal-transplant recipients transfused with donor-specific blood. Transplant Proc 37:927-929. doi:10.1016/j.transproceed.2004.12.289 (Pubitemid 40590746)
2. Amemiya H (1996) 15-Deoxyspergualin: a newly developed immunosuppressive agent and its mechanism of action and clinical effect: a review. Japan Collaborative Transplant Study Group for NKT-01. Artif Organs 20:832-835
3. Arnold-Schild D, Hanau D, Spehner D, Schmid C, Rammensee HG, de la Salle H, Schild H (1999) Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J Immunol 162:3757-3760 (Pubitemid 29314749)
4. Asea A (2006) Initiation of the immune response by extracellular Hsp72: chaperokine activity of Hsp72. Curr Immunol Rev 2:209-215. doi:10.2174/ 157339506778018514
5. Asea A, Kabingu E, Stevenson MA, Calderwood SK (2000) HSP70 peptide-bearing and peptide-negative preparations act as chaperokines. Cell Stress Chaperones 5:425-431. doi:10.1379/1466-1268(2000)005〈0425: HPBAPN〉2.0.CO;2 (Pubitemid 32057493)
6. Bendz H, Ruhland SC, Pandya MJ, Hainzl O, Riegelsberger S, Brauchle C, Mayer MP, Buchner J, Issels RD, Noessner E (2007) Human heat shock protein 70 enhances tumor antigen presentation through complex formation and intracellular antigen delivery without innate immune signaling. J Biol Chem 282:31688-31702. doi:10.1074/jbc.M704129200 (Pubitemid 350044903)
7. Birck R, Warnatz K, Lorenz HM, Choi M, Haubitz M, Grunke M, Peter HH, Kalden JR, Gobel U, Drexler JM, Hotta O, Nowack R, Van Der Woude FJ (2003) 15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy. J Am Soc Nephrol 14:440-447. doi:10.1097/01.ASN.0000048716.42876.14 (Pubitemid 36150868)
8. Calderwood SK, Mambula SS, Gray PJ Jr. (2007) Extracellular heat shock proteins in cell signaling and immunity. Ann N Y Acad Sci 1113:28-39. doi:10.1196/annals.1391.019
9. Delneste Y, Magistrelli G, Gauchat J, Haeuw J, Aubry J, Nakamura K, Kawakami-Honda N, Goetsch L, Sawamura T, Bonnefoy J, Jeannin P (2002) Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17:353-362. doi:10.1016/S1074-7613(02)00388-6 (Pubitemid 35279555)
10. Doody AD, Kovalchin JT, Mihalyo MA, Hagymasi AT, Drake CG, Adler AJ (2004) Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+T cell effector function. J Immunol 172:6087-6092
11. Enomoto Y, Bharti A, Khaleque AA, Song B, Liu C, Apostolopoulos V, Xing PX, Calderwood SK, Gong J (2006) Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells. J Immunol 177:5946-5955 (Pubitemid 44628808)
12. Erickson VR, Hwang PH (2007) Wegener's granulomatosis: current trends in diagnosis and management. Curr Opin Otolaryngol Head Neck Surg 15:170-176. doi:10.1097/MOO.0b013e3281568b96 (Pubitemid 46701353)
13. Facciponte JG, MacDonald IJ, Wang XY, Kim H, Manjili MH, Subjeck JR (2005) Heat shock proteins and scavenger receptors: role in adaptive immune responses. Immunol Invest 34:325-342. doi:10.1081/IMM-200064505 (Pubitemid 41176821)
14. Facciponte JG, Wang XY, Subjeck JR (2007) Hsp110 and Grp170, members of the Hsp70 superfamily, bind to scavenger receptor-a and scavenger receptor expressed by endothelial cells-I. Eur J Immunol 37:2268-2279. doi:10.1002/eji.200737127
15. Hauser H, Shen L, Gu QL, Krueger S, Chen SY (2004) Secretory heat-shock protein as a dendritic cell-targeting molecule: a new strategy to enhance the potency of genetic vaccines. Gene Ther 11:924-932. doi:10.1038/sj.gt.3302160 (Pubitemid 38786607)
16. Hotta O, Furuta T, Chiba S, Yusa N, Taguma Y (1999) Immunosuppressive effect of deoxyspergualin in proliferative glomerulonephritis. Am J Kidney Dis 34:894-901. doi:10.1016/S0272-6386(99)70048-X (Pubitemid 29521707)
17. Kamiguchi K, Torigoe T, Fujiwara O, Ohshima S, Hirohashi Y, Sahara H, Hirai I, Kohgo Y, Sato N (2008) Disruption of the association of 73 kD heat shock cognate protein with transporters associated with antigen processing (TAP) decreases TAP-dependent translocation of antigenic peptides into the endoplasmic reticulum. Microbiol Immunol 52:94-106. doi:10.1111/j.1348-0421. 2008.00017.x
18. Kawada M, Masuda T, Ishizuka M, Takeuchi T (2002) 15-Deoxyspergualin inhibits Akt kinase activation and phosphatidylcholine synthesis. J Biol Chem 277:27765-27771. doi:10.1074/jbc.M200318200 (Pubitemid 34966721)
19. Kozaki K, Kozaki M, Nagao T (1999) Usefulness of 15-deoxyspergualin for rejection in renal transplantation. Transplant Proc 31:1138-1139. doi:10.1016/S0041-1345(98)01937-X (Pubitemid 29127844)
20. Kurotaki T, Tamura Y, Ueda G, Oura J, Kutomi G, Hirohashi Y, Sahara H, Torigoe T, Hiratsuka H, Sunakawa H, Hirata K, Sato N (2007) Efficient cross-presentation by heat shock protein 90-peptide complex-loaded dendritic cells via an endosomal pathway. J Immunol 179:1803-1813
21. Li D, Li H, Zhang P, Wu X, Wei H, Wang L, Wan M, Deng P, Zhang Y, Wang J, Liu Y, Yu Y (2006) Heat shock fusion protein induces both specific and nonspecific anti-tumor immunity. Eur J Immunol 36:1324-1336. doi:10.1002/eji.200535490
22. Lipsker D, Ziylan U, Spehner D, Proamer F, Bausinger H, Jeannin P, Salamero J, Bohbot A, Cazenave JP, Drillien R, Delneste Y, Hanau D, de la Salle H (2002) Heat shock proteins 70 and 60 share common receptors which are expressed on human monocyte-derived but not epidermal dendritic cells. Eur J Immunol 32:322-332. doi:10.1002/1521-4141(200202)32:2〈322::AID- IMMU322〉3.0.CO;2-0 (Pubitemid 34173323)
23. Lorenz HM, Grunke M, Wendler J, Heinzel PA, Kalden JR (2005) Safety of 15-deoxyspergualin in the treatment of glomerulonephritis associated with active systemic lupus erythematosus. Ann Rheum Dis 64:1517-1519. doi:10.1136/ard.2005. 035329 (Pubitemid 41623872)
24. Manjili MH, Park J, Facciponte JG, Subjeck JR (2005) HSP110 induces "danger signals" upon interaction with antigen presenting cells and mouse mammary carcinoma. Immunobiology 210:295-303. doi:10.1016/j.imbio.2005.04. 002
25. Massa C, Melani C, Colombo MP (2005) Chaperon and adjuvant activity of hsp70: different natural killer requirement for cross-priming of chaperoned and bystander antigens. Cancer Res 65:7942-7949 (Pubitemid 41297273)
26. Nadeau K, Nadler SG, Saulnier M, Tepper MA, Walsh CT (1994) Quantitation of the interaction of the immunosuppressant deoxyspergualin and analogs with Hsc70 and Hsp90. Biochemistry 33:2561-2567. doi:10.1021/bi00175a027 (Pubitemid 24099664)
27. Nadler SG, Dischino DD, Malacko AR, Cleaveland JS, Fujihara SM, Marquardt H (1998) Identification of a binding site on Hsc70 for the immunosuppressant 15-deoxyspergualin. Biochem Biophys Res Commun 253:176-180. doi:10.1006/bbrc. 1998.9775 (Pubitemid 29015620)
28. Nadler SG, Eversole AC, Tepper MA, Cleaveland JS (1995) Elucidating the mechanism of action of the immunosuppressant 15-deoxyspergualin. Ther Drug Monit 17:700-703. doi:10.1097/00007691-199512000-00026
29. Nadler SG, Tepper MA, Schacter B, Mazzucco CE (1992) Interaction of the immunosuppressant deoxyspergualin with a member of the Hsp70 family of heat shock proteins. Science 258:484-486. doi:10.1126/science.1411548
30. Noessner E, Gastpar R, Milani V, Brandl A, Hutzler PJ, Kuppner MC, Roos M, Kremmer E, Asea A, Calderwood SK, Issels RD (2002) Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells. J Immunol 169:5424-5432 (Pubitemid 35291639)
31. Nomura Y, Tomikawa S, Beck Y, Nishimura Y, Meigata K, Ando Y, Kikuchi K (1998) Effect of deoxyspergualin on acute and chronic rejection in renal transplantation. Transplant Proc 30:3580-3581. doi:10.1016/S0041-1345(98)01144-0 (Pubitemid 128712745)
32. Pido-Lopez J, Whittall T, Wang Y, Bergmeier LA, Babaahmady K, Singh M, Lehner T (2007) Stimulation of cell surface CCR5 and CD40 molecules by their ligands or by HSP70 up-regulates APOBEC3G expression in CD4(+) T cells and dendritic cells. J Immunol 178:1671-1679 (Pubitemid 46154639)
33. Roelofs MF, Boelens WC, Joosten LA, Abdollahi-Roodsaz S, Geurts J, Wunderink LU, Schreurs BW, van den Berg WB, Radstake TR (2006) Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. J Immunol 176:7021-7027 (Pubitemid 43787883)
34. Schmitt WH, Birck R, Heinzel PA, Gobel U, Choi M, Warnatz K, Peter HH, van der Woude FJ (2005) Prolonged treatment of refractory Wegener's granulomatosis with 15-deoxyspergualin: an open study in seven patients. Nephrol Dial Transplant 20:1083-1092. doi:10.1093/ndt/gfh763 (Pubitemid 40862096)
35. SenGupta D, Norris PJ, Suscovich TJ, Hassan-Zahraee M, Moffett HF, Trocha A, Draenert R, Goulder PJ, Binder RJ, Levey DL, Walker BD, Srivastava PK, Brander C (2004) Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II. J Immunol 173:1987-1993 (Pubitemid 38971635)
36. Srivastava PK, Udono H (1994) Heat shock protein-peptide complexes in cancer immunotherapy. Curr Opin Immunol 6:728-732. doi:10.1016/0952-7915(94) 90076-0 (Pubitemid 24312140)
37. Tamura Y, Peng P, Liu K, Daou M, Srivastava PK (1997) Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 278:117-120. doi:10.1126/science.278.5335.117 (Pubitemid 27446289)
38. Todryk S, Melcher AA, Hardwick N, Linardakis E, Bateman A, Colombo MP, Stoppacciaro A, Vile RG (1999) Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J Immunol 163:1398-1408 (Pubitemid 29352760)
39. Ueda G, Tamura Y, Hirai I, Kamiguchi K, Ichimiya S, Torigoe T, Hiratsuka H, Sunakawa H, Sato N (2004) Tumor-derived heat shock protein 70-pulsed dendritic cells elicit tumor-specific cytotoxic T lymphocytes (CTLs) and tumor immunity. Cancer Sci 95:248-253. doi:10.1111/j.1349-7006.2004.tb02211.x (Pubitemid 38489092)
40. Waaga AM, Fandrich F, Krzymanski M, Eckstein V, Herwartz C, Muller-Ruchholtz W, Russell ME (1996) 15-deoxyspergualin downregulates MHC class II antigen expression and cell migration in models of graft-versus-host and host-versus-graft disease. Transplant Proc 28:2515-2517 (Pubitemid 26339370)
41. Wang XH, Qin Y, Hu MH, Xie Y (2005) Dendritic cells pulsed with gp96-peptide complexes derived from human hepatocellular carcinoma (HCC) induce specific cytotoxic T lymphocytes. Cancer Immunol Immunother 54:971-980. doi:10.1007/s00262-005-0662-9 (Pubitemid 41187705)
42. Warger T, Hilf N, Rechtsteiner G, Haselmayer P, Carrick DM, Jonuleit H, von Landenberg P, Rammensee HG, Nicchitta CV, Radsak MP, Schild H (2006) Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses. J Biol Chem 281:22545-22553. doi:10.1074/jbc.M502900200 (Pubitemid 44242283)